¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"receptor down regulation"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® Down syndrome ÇÑ±Û ´Ù¿îÁõÈıº
¼³¸í   
  »ç¶÷ÀÇ 46°³ ¿°»öü Áß Á¦ 21¹ø ¿°»öüÀÇ ¼ö°¡ 1°³ ´õ ¸¹¾ÆÁö¹Ç·Î½á ³ªÅ¸³ª´Â º´ÀÌ´Ù. È¯ÀÚÀÇ »ý±è»õ°¡ ¸¶Ä¡ ¸ù°í »ç¶÷°ú ´à¾Ò´Ù ÇÏ¿© ÀÏ¸í ¸ù°íÁõ(mongolism)À̶ó°í ÇÏ¿´À¸³ª À߸øµÈ À̸§ÀÌ´Ù. ÀÌ º´Àº ¹Ýµå½Ã 21¹ø ¿°»öü°¡ 3°³°¡ µÇ´Â °æ¿ìÀ̿ܿ¡µµ 21¹ø ¿°»öüÀÇ ÀϺκÐÀÌ ´Ù¸¥ ¿°»öüÀÇ ÀϺκаú ±³È¯ÀÌ µÇ´Â translocationÇü µîÀÇ ´Ù¸¥ ¿°»öüÀ̻󿡼­µµ º¼ ¼ö°¡ ÀÖ´Ù. ¹ß»ý ºóµµ´Â Ãâ»ý¾Æ 700~1000¸íÁß 1¸í ²Ã·Î ³ªÅ¸³ª¸ç, ¿°»öü À̻󺴠Áß¿¡ °¡Àå ¸¹Àº °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ÀÌ º´ÀÇ ¹ß»ýºóµµ´Â »ê¸ðÀÇ Ãâ»ê¿¬·É°ú ¹ÐÁ¢ÇÑ °ü°è°¡ ÀÖ¾î, 35¼¼ ÀÌÈİ¡ µÇ¸é ±âÇÏ ±Þ¼öÀûÀ¸·Î ÀÌ ÁúȯÀÚÀÇ Ãâ»ê¼ö°¡ Áõ°¡ÇÑ´Ù. ÀϹÝÀûÀ¸·Î ÀÌ Áúȯ¿¡ À־ ¾à 3ºÐÀÇ 1Àº ¸ðÄ£ÀÇ Ãâ»ê¿¬·É¿¡ ÀÇÁ¸ÇÏÁö ¾Ê°í, ³ª¸ÓÁö ¾à 3ºÐÀÇ 2´Â ¸ðÄ£ÀÇ ¿¬·É°ú Á÷Á¢ °ü·ÃÀÌ Àִ °ÍÀ¸·Î º¸°í ÀÖ´Ù. Áø´ÜÀº Æ¯Â¡ÀûÀΠ»ý±è»õ, Áï ¸ù°í »ç¶÷°°ÀÌ ´«²¿¸®°¡ À§·Î Ä¡ÄÑÁ® ÀÖ°í ´«°ÅÇ®ÀÌ µÎ²¨¿ì¸ç ÄàµîÀÌ ³·Àº Æ¯Â¡ÀûÀΠ¾ó±¼ ¸ð½À, ¶ÇÇÑ ±ÙÀ°ÀÇ ±äÀåµµ°¡ ÀúÇϵǰí Á¥À» ºü´Â Èû°ú ¿ïÀ½ ¼Ò¸®°¡ ¾àÇϸ砼չٴÚÀÇ Á¿츦 °¡¸£´Â ÇÑÁÙÀÇ ¼Õ±Ý(¿ø¼þÀ̿͠°°Àº ÇüÅÂÀÌ´Ù) µîÀǠƯ¡ÀûÀΠ¼Ò°ß¿¡ ÀÇÇØ º¸Á¶Áø´ÜÀ» Çϰí ÃÖÁ¾ÀûÀ¸·Î ¿°»öü ºÐ¼®¿¡ ÀÇÇØ È®ÁøÀ» ÇÑ´Ù. ÀÌ ´Ù¿îÁõÈıºÀǠȯÀڴ ´ë°³ Áö´ÉÀÌ ÀúÇϵǾî ÀÖ°í, ¿©·¯ °¡Áö Á¾·ùÀÇ ¼±Ãµ¼º ½ÉÀå±âÇüÀ» ¸¹ÀÌ µ¿¹ÝÇϰí ÀÖ´Ù.
¿µ¹® receptor ÇÑ±Û ¼ö¿ëü
¼³¸í   
  ¼¼Æ÷Áú³» ¶Ç´Â ¼¼Æ÷Ç¥¸é¿¡ Á¸ÀçÇϴ ºÐÀÚ±¸Á¶·Î¼­ Æ¯À̹°Áú°ú ¼±ÅÃÀûÀ¸·Î °áÇÕÇϸ砰áÇÕ¿¡ ÀÇÇØ Æ¯ÀÌÇÑ »ý¸®Àû ÀÛ¿ëÀ» ³ªÅ¸³½´Ù. ÆéƼµåÈ£¸£¸ó, ½Å°æÀü´Þ¹°Áú, Ç׿ø, º¸Ã¼, ¸é¿ª±Û·ÎºÒ¸°¿¡ ´ëÇÑ ¼¼Æ÷Ç¥¸é ¼ö¿ëü¿Í ½ºÅ×·ÎÀ̵忡 ´ëÇÑ ¼¼Æ÷Áú³» ¼ö¿ëü°¡ ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • down regulation
    ÇÏÇâÁ¶Àý
  • cone down
    Á¶»ç¿µ¿ªÃà¼Ò
  • cone down technique
    Á¶»ç¿µ¿ªÃà¼Ò¹ý
  • down bearing
    ºÐ¸¸ÈûÁÖ±â
  • Down syndrome
    ´Ù¿îÁõÈıº
  • ring-down artifact
    ¿©¿îÇã»ó, ¿©¿îÀΰø¹°
  • step-down transformer
    °­¾Ðº¯¾Ð±â
  • gene regulation
    À¯ÀüÀÚÁ¶Àý
  • genetic regulation
    À¯ÀüÀûÁ¶Àý
  • global regulation
    Åë°ýÁ¶Àý
  • humoral regulation
    ü¾×Á¶Àý
  • ionic regulation
    ÀÌ¿ÂÁ¶Àý
  • metabolic regulation
    ´ë»çÁ¶Àý
  • osmotic regulation
    »ïÅõ¾ÐÁ¶Àý
  • regulation
    1. ±ÔÁ¤ 2. Á¶Àý
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • down bearing
    ºÐ¸¸ÈûÁÖ±â
  • regulation
    ±ÔÁ¤, Á¶Àý
  • respiration regulation
    È£ÈíÁ¶Àý
  • self regulation
    ÀÚ°¡Á¶Àý
  • receptor blocker
    ¼ö¿ëüÂ÷´ÜÁ¦
  • receptor binding
    ¼ö¿ëü°áÇÕ
  • receptor
    ¼ö¿ëü, ¼ö¿ë±â
  • antigen receptor
    Ç׿ø¼ö¿ëü
  • opiate receptor
    ¾ÆÆí¼ö¿ëü
  • sensory receptor
    °¨°¢¼ö¿ëü
  • receptor site
    ¼ö¿ëüºÎÀ§
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • down regulation
    ÇÏÇâÁ¶Àý
  • ring-down artifact
    ¿©¿îÇã»ó, ¿©¿îÀΰø¹°
  • cone down technique
    Á¶»ç¿µ¿ªÃà¼Ò¹ý
  • down phenomenon
    »õº®Çö»ó, ¿©¸íÇö»ó
  • face down position
    (¢¡prone position) ¾þµå¸°ÀÚ¼¼, º¹¿ÍÀ§
  • step-down heating
    ´Ü°èº°°¨¿Â
  • step-down transformer
    °­¾Ðº¯¾Ð±â
  • gene regulation
    À¯ÀüÀÚÁ¶Àý
  • genetic regulation
    À¯ÀüÀûÁ¶Àý
  • global regulation
    Åë°ýÁ¶Àý
  • heat regulation
    ¿­Á¶Àý
  • humoral regulation
    ü¾×Á¶Àý
  • ionic regulation
    ÀÌ¿ÂÁ¶Àý
  • metabolic regulation
    ´ë»çÁ¶Àý
  • osmotic regulation
    »ïÅõ¾ÐÁ¶Àý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Down syndrome
    ´Ù¿îÁõÈıº
  • prism base-down
    ¹Ù´Ú¾Æ·¡ÇÁ¸®Áò
  • Glucostatic hypothesis, of appetite regulation
    Ç×´ç±â¼³(ù÷ÓØÐñæò), ½Ä¿åÁ¶Àý(ãÝé¯ðàï½)
  • genetic regulation
    À¯ÀüÀû Á¶Àý.
  • genetic regulation
    À¯ÀüÀûÁ¶Àý
  • global regulation
    Åë°ýÁ¶Àý
  • heat regulation
    ü¿Â(¿­)Á¶Àý(ô÷è®æððàï½).
  • regulation
    ±ÔÁ¤
  • regulation of acid base equilibrium
    »ê-¿°±âÆòÇüÁ¶Àý(ß«ç¤ÐñøÁû¬ðàï½).
  • regulation of body temperature
    ü¿ÂÁ¶Àý(ô÷è®ðàï½).
  • regulation of gastric secretion
    À§»êºÐºñÁ¶Àý(êÖß«ÝÂù²ðàï½).
  • A1 receptor
    A1 ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â)
  • A2 receptor
    A2 ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â)
  • CR1 => complement receptor 1
    º¸Ã¼¼ö¿ëü 1
  • CR2 => complement receptor 2
    º¸Ã¼¼ö¿ëü 2
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • down regulation
    ÇÏÇâÁ¶Àý
  • down-regulation (of receptors)
    (¼ö¿ëü)ÇÏÇâÁ¶Àý.
  • down-regulation (of receptors)
    ¼ö¿ëü(áôé»ô÷)ÇÏÇâÁ¶Àý(ù»ú¾ðàï½).
  • bound down muscle
    À¯Âø±Ù
  • build-down
    °¨, ²ø¾î³»¸², Á¡Â÷³»¸²
  • cone down technique
    Á¶»ç¿µ¿ªÃà¼Ò¹ý
  • cut down
    Ç÷°üÀý°³(¼ú).
  • down
    ¼ØÅС쵿¹°ÀÇ¡í
  • down
    ¼ØÅС쵿¹°ÀÇ¡í.
  • down phenomenon
  • down syndrome
    ´Ù¿îÁõÈıº(¡­ñøý¦ÏØ)
  • face down position
    º¹¿ÍÀ§.
  • mongolism =Down s syndrome
    ¸ù°íÁõ(ÙÕ Í¯ñø).
  • mongolism =down s syndrome
    ¸ù°íÁõ(ÙÕͯñø)
  • prism base-down
    ¹Ù´Ú¾Æ·¡ÇÁ¸®Áò
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Receptor
    ¼ö¿ë±â
    [¿¾ ¿ë¾î] ¼ö¿ë±â
  • Syndrome (Down)
    ÁõÈıº (´Ù¿îÁõÈıº)
    [¿¾ ¿ë¾î] ÁõÈÄ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • receptor down regulation
    ¼ö¿ëü ÇÏÇâ Á¶Àý(áôé»ô÷ù»ú¾ðàï½)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • down regulation
    ÇÏÇâ Á¶Àý(ù»ú¾ðàï½)
  • coordinate regulation
    "µ¿Á¶Á¶Á¤(ÔÒðàðàïÚ), (ÔÒ) coordinate induction, coordinate"
  • down promoter mutation
    ÇÏÇâÃËÁøÀÚ º¯ÀÌ(ù»ú¾õµòäí­Ü¨ì¶) (ÔÒ) promoter down mutation
  • Down's syndrome
    ´Ù¿î ÁõÈıº(ñøý¦ÏØ) (ÔÒ) mongolism
  • negative regulation
    À½Á¶Àý(ëäðàï½)
  • positive regulation
    "°¡Á¶Àý(ʦðàï½), ¾ç±ØÁ¶Àý(åÕпðàï½)"
  • promoter-down mutation
    ÇÁ·Î¸ðÅÍ ±â´ÉÀúÇÏ º¯ÀÌ(ѦÒöî¸ù»Ü¨ì¶)
  • adrenergic receptor
    ¾Æµå·¹³¯¸°ÀÛµ¿(íÂÔÑ) ¼ö¿ëü(áôé»ô÷)
  • alpha adrenergic receptor
    ¾ËÆÄ¾Æµå·¹³ª¸°ÀÛµ¿¼º(íÂÔÑàõ) ¼ö¿ëü(áôé»ô÷)
  • alpha receptor
    ¾ËÆÄ¼ö¿ëü(áôé»ô÷)
  • beta adrenergic receptor
    º£Å¸ ¾Æµå·¹³¯¸° ¼ö¿ëü(áôé»ô÷)
  • beta receptor
    º£Å¸ ¼ö¿ëü(áôé»ô÷)
  • cyclic AMP receptor protein
    °í¸®AMP ¼ö¿ëü ´Ü¹éÁú(áôé»ô÷Ó±ÛÜòõ)
  • dopamine adrenergic receptor
    "µµÆÄ¹Î ¾Æµå·¹³¯¸°ÀÛµ¿¼º(íÂÔÑàõ) ¼ö¿ëü(áôé»ô÷), (ÔÒ) adrenergic receptor"
  • Ehrlich's receptor theory
    ¿¡¸¦¸®È÷ ¼ö¿ëüÀÌ·Ð(áôé»ô÷×âÖå)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • receptor
    ¼ö¿ë±â, ¼ö¿ëü, °¨¼öü
  • regulation
    ±ÔÁ¤, Á¶Á¤, Á¶Àý
  • cut down
    Ç÷°üÀý°³¼ú
  • ring down
    ¿©¿î
  • ring down time
    ¿©¿î½Ã°£
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
FAR Federal acquisitions regulation; fractional albumin rate; fresh bone marrow
FR failure rate; film-screen radiograph; fasciculus retroflexus; febrile reaction; feedback regulation;...
IRIS integrated risk information system; interleukin regulation of immune system; International Research ...
ER efficiency ratio; epigastric region; ejection rate; electroresection; emergency room; endoplasmic re...
RAR rapidly adapting receptor; rat insulin receptor; retinoic acid receptor; right arm reclining; right ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
BDP break down product
dra Down Regulated in Adenoma
DS Down Syndrome
HDT Head Down Tilt
SDH Step-down heating
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • down-regulation of receptor
    ¼ö¿ëü ÇÏÇâ Á¶Àý
  • down regulation
    ÇÏÇâ Á¶Àý
    È£¸£¸óÀÇ ÀÛ¿ë ±âÀü¿¡¼­´Â È£¸£¸óÀÇ ³óµµ°¡ Áö¼ÓÀûÀ¸·Î Áõ°¡ÇØ ÀÖÀ¸¸é Ç¥Àû ¼¼Æ÷´Â ¼ö¿ëüÀÇ ¼ö¸¦ °¨¼Ò½ÃŰ´Â ¹ÝÀÀÀ» ÇÏ¸ç ±× °á°ú È£¸£¸óÀÇ °¨¼ö¼ºÀÌ °¨¼ÒÇÏ°Ô µÇ´Âµ¥ À̸¦ ÇÏÇâ Á¶ÀýÀ̶ó°í ÇÑ´Ù.
  • appetite regulation
    ½Ä¿å Á¶Àý
  • bearing-down pain
    ¾ÐÇÏÅë
    ºÐ¸¸ Á¦2±âÀÇ Àڱà ¼öÃà°ú µ¿¹ÝÇÏ¿© ÀϾ´Â µ¿Åë.
  • down
    ¼ØÅÐ
  • face down position
    º¹¿ÍÀ§
  • feedback regulation
    ÇÇÀ̵å¹é ¾ïÁ¦
    Ç×ü°¡ Á¸ÀçÇÔÀ¸·Î½á ±× Ç×ü¿¡ ÀÇÇÑ negativeÀÇ ±â±¸°¡ À¯µµµÇ¾î °°Àº ƯÀ̼ºÀ» °¡Áø Ç×ü »ý»êÀÌ ¾ïÁ¦µÇ´Â Çö»ó.
  • humoral regulation
    ü¾×¼º Á¶Àý
  • ionic regulation
    À̿ Á¶Àý
  • Langdon-Down's disease
    ·©µ·-´Ù¿î º´
  • let-down reflex
    ÃÖÀ¯ ¹Ý»ç
  • lying-down dysentery
    ¼¼±Õ¼º ÀÌÁú
    ¾Æ¸Þ¹Ù ÀÌÁúÀ» º¸ÇàÀÌ ÁúÀ̶ó Çϴµ¥ ´ëÇØ ¼¼±Õ¼º ÀÌÁúÀ» Ⱦ¿Í ÀÌÁúÀ̶ó°í ÇÑ´Ù.
  • osmotic regulation
    »ïÅõ¾Ð Á¶Àý
  • paracrine regulation
    ÁÖÀ§ ºÐºñ Á¶Àý
  • regulation of body temperature
    ü¿Â Á¶Àý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
down-regulation <physiology> Development of a refractory or tolerant state consequent upon repeated administration of a pharmacologically or physiologically active substance.
It is the process that decreases ligand and receptor interactions or reduces the responsiveness of a cell to a stimulus following first exposure.
This is often accompanied by an initial decrease in affinity of receptors for the agent and a subsequent reduction in the number of available receptors expressed on the surface which can result from internalisation of the ligand:receptor complex or from decreased expression of the receptor.
Classically the concept referred to hormone receptors but contemporary usage includes other cell surface receptors.
(03 Jul 1999)
bearing down Expulsive effort of a parturient woman in the second stage of labour.
(05 Mar 2000)
bearing-down pain A uterine contraction accompanied by straining and tenesmus; usually appearing in the second stage of labour.
(05 Mar 2000)
reflex, let down The let down reflex of the mother is an involuntary reflex during breastfeeding which causes the milk to flow freely.
(12 Dec 1998)
milk let-down reflex Release of milk from the breast following tactile stimulation of the nipple; the afferent path is postulated to exist from the nipple to the hypothalamus; the efferent limb is represented by the neurohypophysial release of oxytocin into the systemic circulation; contraction of myoepithelial elements within the breast, caused by oxytocin, moves milk into the collecting ducts and toward the nipple.
Synonym: let-down reflex, milk let-down reflex.
(05 Mar 2000)
cone down To narrow a beam of X-rays to a region of interest using a collimator or cone; colloq., to delimit one's attention or activities.
(05 Mar 2000)
head-down tilt Posture while lying with the head lower than the rest of the body. Extended time in this position is associated with temporary physiologic disturbances.
(12 Dec 1998)
syndrome, down A common disorder due to a chromosome abnormality and specfically due to an extra chromosome number 21 (trisomy 21). Down syndrome includes mental retardation, a characteristic face, and multiple malformations. It is associated with a major risk for heart problems, a lesser risk of duodenal atresia (part of the intestines not developed), and a minor but still significant risk of acute leukaemia. The name down syndrome comes from the 19th century english doctor langdon down, a misnomer since he was curiously enough not the first person to describe the condition and, in great error, attributed the condition to a reversion to the mongoloid race. Hence, the old name mongolism, now considered slang.
(12 Dec 1998)
down <dermatology, zoology> Fine, soft feathers, soft, fine hair.
(04 Mar 1998)
Down, John Langdon <person> English physician, 1828-1896.
See: Down's syndrome.
(05 Mar 2000)
down promoter mutation <molecular biology> A mutation (a change in base pair sequence) in a promoter region, this results in lower gene expression (less transcription of the gene occurs).
(09 Oct 1997)
Down's syndrome <genetics, syndrome> A congenital disorder in which a person is born with three copies of chromosome 21 (trisomy 21).
Clinical features include moderate to severe mental retardation, slanting eyes, a broad short skull, broad hands and short fingers. Other congenital abnormalities include heart defects, oesophageal atresia and an increased incidence of acute lymphocytic leukaemia.
Trisomy 21 can be detected in the first few months of pregnancy by amniocentesis. Risk factors include prior child with Down's syndrome and mothers who become pregnant after age 40. This disorder was formerly known as mongolism.
Incidence: 1 in 1000 births.
(09 Oct 1997)
down syndrome <radiology> Trisomy 21, mongolism, atlantoaxial subluxation, Wormian bones, absent/small paranasal sinuses, endocardial cushion (AV canal) defects, aberrant right subclavian artery, 2 ossification centres for manubrium (90%), 11 or 13 ribs, duodenal atresia / stenosis, tracheo-oesophageal fistula, Hirschsprung disease
(12 Dec 1998)
turn down ratio The lowest load at which a boiler will operate efficiently as compared to the boiler's maximum design load.
(05 Dec 1998)
let-down reflex <neurology, paediatrics> An involuntary reflex during breast feeding which causes the milk to flow freely.
See: milk-ejection reflex
(22 Sep 2002)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • receptor
    ¼ö¿ë±â;°¨°¢±â°ü;¼ö¿ëü
  • receptor site
    ¼¼Æ÷³» ¼ö¿ë ¿µ¿ª
  • regulation
    ±ÔÁ¤; Á¶Àý; ±ÔÁ¦; ÅëÁ¦
  • regulation
    ´Ü¼Ó;±ÔÁ¦;Á¶Àý;Á¶Á¤;±ÔÄ¢;±ÔÁ¤;¹ý±Ô;Á¤±ÔÀÇ;±ÔÁ¤ÀÇ;Ç¥ÁØÀÇ;Á¤»óÀÇ;º¸ÅëÀÇ;¿¹ÀÇ;¿©´À
  • regulation mourning
    Á¤½Ä »ó 
  • regulation speed
    ±ÔÁ¤(¹ýÁ¤) ¼Óµµ
  • blow down
    ³Ñ¾î¶ß¸®´Ù
  • break down
    °íÀ峪´Ù; ºØ±«ÇÏ´Ù; ½Ç¸ÁÇÏ´Ù
  • bring down
    (ÁüÀ»)³»¸®´Ù; Ç϶ô½ÃŰ´Ù
  • broken-down
    ¼è¾àÇØÁø
  • cast down
    ³Ñ¾î¶ß¸®´Ù; ³«´ã½ÃŰ´Ù
  • come down
    ¶³¾îÁö´Ù;°ªÀ̳»¸®´Ù;ÀüÇØÁ®¿À´Ù
  • come down with
    (º´¿¡)°É¸®´Ù
  • cut down
    ÁÙÀÌ´Ù; »è°¨ÇÏ´Ù; ¾²·¯¶ß¸®´Ù
  • die down
    Â÷Â÷ »ç¶óÁö´Ù
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á